Anti-tumor effects of tirbanibulin in squamous cell carcinoma cells are mediated via disruption of tubulin-polymerization
Archives of Dermatological Research · 2024
DOI: 10.1007/s00403-024-03032-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Dermatological Research, 2024. Verfasst von Viola K DeTemple und 4 weiteren Autor:innen. Beteiligte Einrichtung: Universitätsklinik für Dermatologie, Venerologie, Allergologie und Phlebologie, Johannes Wesling Klinikum Minden, Universitätsklinik der Ruhr-Univers…. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Keratinocytes, Tubulin, Skin Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Almirall, Ruhr-Universität Bochum.
Abstract (Originalsprache)
Topical tirbanibulin is a highly effective and well tolerated novel treatment option for actinic keratoses (AKs). This study aimed to characterize the mode of action of tirbanibulin in keratinocytes (NHEK) and cutaneous squamous cell carcinoma (cSCC) cell lines (A431, SCC-12) in vitro. Tirbanibulin significantly reduced proliferation in a dose-dependent manner in all investigated cell lines, inhibited migration, and induced G2/M-cell cycle arrest only in the cSCC cell lines analyzed, and induced apoptosis solely in A431, which showed the highest sensitivity to tirbanibulin. In general, we detected low basal expression of phosphorylated SRC in all cell lines analyzed, therefore, interference with SRC signaling does not appear to be the driving force regarding the observed effects of tirbanibulin. The most prominent tirbanibulin-mediated effect was on β-tubulin-polymerization, which was especially impaired in A431. Additionally, tirbanibulin induced an increase of the proinflammatory cytokines IL-1α, bFGF and VEGF in A431. In conclusion, tirbanibulin mediated anti-tumor effects predominantly in A431, while healthy keratinocytes and more dedifferentiated SCC-12 were less influenced. These effects of tirbanibulin are most likely mediated via dysregulation of β-tubulin-polymerization and may be supported by proinflammatory aspects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Universitätsklinik für Dermatologie, Venerologie, Allergologie und Phlebologie, Johannes Wesling Klinikum Minden, Universitätsklinik der Ruhr-Universität Bochum, Hans-Nolte-Straße 1, 32429, Minden, Germany. violakathari…
- Klinik für Dermatologie, Allergologie und Venerologie, Hauttumorzentrum Hannover, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
- Universitätsklinik für Dermatologie, Venerologie, Allergologie und Phlebologie, Johannes Wesling Klinikum Minden, Universitätsklinik der Ruhr-Universität Bochum, Hans-Nolte-Straße 1, 32429, Minden, Germany.
ORCID-Profile: Viola K DeTemple, Antje Walter, Sabine Bredemeier, Ralf Gutzmer, Katrin Schaper-Gerhardt
Förderung
- Almirall
- Ruhr-Universität Bochum
Zitieren
APA
DeTemple, V. K., Walter, A., Bredemeier, S., Gutzmer, R., & Schaper-Gerhardt, K. (2024). Anti-tumor effects of tirbanibulin in squamous cell carcinoma cells are mediated via disruption of tubulin-polymerization. Archives of Dermatological Research. https://doi.org/10.1007/s00403-024-03032-x
Vancouver
DeTemple VK, Walter A, Bredemeier S, Gutzmer R, Schaper-Gerhardt K. Anti-tumor effects of tirbanibulin in squamous cell carcinoma cells are mediated via disruption of tubulin-polymerization. Archives of Dermatological Research. 2024. doi:10.1007/s00403-024-03032-x
BibTeX
@article{DeTemple2024,
author = {DeTemple, Viola K and Walter, Antje and Bredemeier, Sabine and Gutzmer, Ralf and Schaper-Gerhardt, Katrin},
title = {Anti-tumor effects of tirbanibulin in squamous cell carcinoma cells are mediated via disruption of tubulin-polymerization},
journal = {Archives of Dermatological Research},
year = {2024},
doi = {10.1007/s00403-024-03032-x}
}
EUVIMED